These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 31917706)
1. Recurrent DICER1 Hotspot Mutations in Malignant Thyroid Gland Teratomas: Molecular Characterization and Proposal for a Separate Classification. Rooper LM; Bynum JP; Miller KP; Lin MT; Gagan J; Thompson LDR; Bishop JA Am J Surg Pathol; 2020 Jun; 44(6):826-833. PubMed ID: 31917706 [TBL] [Abstract][Full Text] [Related]
2. Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations-is the term "thyroblastoma" more appropriate? Agaimy A; Witkowski L; Stoehr R; Cuenca JCC; González-Muller CA; Brütting A; Bährle M; Mantsopoulos K; Amin RMS; Hartmann A; Metzler M; Amr SS; Foulkes WD; Sobrinho-Simões M; Eloy C Virchows Arch; 2020 Dec; 477(6):787-798. PubMed ID: 32507920 [TBL] [Abstract][Full Text] [Related]
3. Malignant teratomas of the thyroid gland: clinico-radiologic and cytomorphologic features of a rare entity. Miller DL; Thompson LDR; Bishop JA; Rooper LM; Ali SZ J Am Soc Cytopathol; 2020; 9(4):221-231. PubMed ID: 32448730 [TBL] [Abstract][Full Text] [Related]
4. From Malignant Thyroid Teratoma to Thyroblastoma: Evolution of a Newly-recognized DICER1 -associated Malignancy. Rooper LM Adv Anat Pathol; 2023 Mar; 30(2):136-145. PubMed ID: 36069850 [TBL] [Abstract][Full Text] [Related]
5. Presacral malignant teratoid neoplasm in association with pathogenic DICER1 variation. Nakano Y; Hasegawa D; Stewart DR; Schultz KAP; Harris AK; Hirato J; Uemura S; Tamura A; Saito A; Kawamura A; Yoshida M; Yamasaki K; Yamashita S; Ushijima T; Kosaka Y; Ichimura K; Dehner LP; Hill DA Mod Pathol; 2019 Dec; 32(12):1744-1750. PubMed ID: 31296931 [TBL] [Abstract][Full Text] [Related]
6. Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations. Chernock RD; Rivera B; Borrelli N; Hill DA; Fahiminiya S; Shah T; Chong AS; Aqil B; Mehrad M; Giordano TJ; Sheridan R; Rutter MM; Dehner LP; Foulkes WD; Nikiforov YE Mod Pathol; 2020 Jul; 33(7):1264-1274. PubMed ID: 31937902 [TBL] [Abstract][Full Text] [Related]
7. Clinical and Molecular Characteristics May Alter Treatment Strategies of Thyroid Malignancies in DICER1 Syndrome. van der Tuin K; de Kock L; Kamping EJ; Hannema SE; Pouwels MM; Niedziela M; van Wezel T; Hes FJ; Jongmans MC; Foulkes WD; Morreau H J Clin Endocrinol Metab; 2019 Feb; 104(2):277-284. PubMed ID: 30260442 [TBL] [Abstract][Full Text] [Related]
8. Predominant Lee YA; Im SW; Jung KC; Chung EJ; Shin CH; Kim JI; Park YJ Thyroid; 2020 Aug; 30(8):1120-1131. PubMed ID: 32228164 [No Abstract] [Full Text] [Related]
9. High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid. Bae JS; Jung SH; Hirokawa M; Bychkov A; Miyauchi A; Lee S; Chung YJ; Jung CK Endocr Pathol; 2021 Sep; 32(3):336-346. PubMed ID: 34313965 [TBL] [Abstract][Full Text] [Related]
10. Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing platform. Ghossein CA; Dogan S; Farhat N; Landa I; Xu B Virchows Arch; 2022 Feb; 480(2):293-302. PubMed ID: 34580763 [TBL] [Abstract][Full Text] [Related]
12. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: DICER1-Related Thyroid Tumors. Sauer M; Barletta JA Head Neck Pathol; 2022 Mar; 16(1):190-199. PubMed ID: 35307774 [TBL] [Abstract][Full Text] [Related]
14. DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid Carcinoma. Wasserman JD; Sabbaghian N; Fahiminiya S; Chami R; Mete O; Acker M; Wu MK; Shlien A; de Kock L; Foulkes WD J Clin Endocrinol Metab; 2018 May; 103(5):2009-2015. PubMed ID: 29474644 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and Spectrum of DICER1 Mutations in Adult-onset Thyroid Nodules with Indeterminate Cytology. Chong AS; Nikiforov YE; Condello V; Wald AI; Nikiforova MN; Foulkes WD; Rivera B J Clin Endocrinol Metab; 2021 Mar; 106(4):968-977. PubMed ID: 33460435 [TBL] [Abstract][Full Text] [Related]
16. Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic DICER1 Gene Mutation: Case Report and Review of the Literature. Hellgren LS; Hysek M; Jatta K; Zedenius J; Juhlin CC Head Neck Pathol; 2021 Jun; 15(2):668-675. PubMed ID: 32712880 [TBL] [Abstract][Full Text] [Related]
17. Atrophic changes in thyroid tumors are strong indicators of underlying DICER1 mutations: a bi-institutional genotype-phenotype correlation study. Condello V; Roberts JW; Stenman A; Larsson C; Viswanathan K; Juhlin CC Virchows Arch; 2024 Jul; 485(1):105-114. PubMed ID: 38637342 [TBL] [Abstract][Full Text] [Related]
19. Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors. Minna E; Devecchi A; Pistore F; Paolini B; Mauro G; Penso DA; Pagliardini S; Busico A; Pruneri G; De Cecco L; Borrello MG; Sensi M; Greco A Front Endocrinol (Lausanne); 2023; 14():1267499. PubMed ID: 37867524 [TBL] [Abstract][Full Text] [Related]
20. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome. Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]